Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-02 Sale(A) | 2026-02-04 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 15,000 | $10.87 | $163,089 | 469,864 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:10 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 15,000 | $10.72 | $160,857 | 454,864 (Direct) | View |
| 2026-01-02 Sale | 2026-01-06 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 15,000 | $11.87 | $178,089 | 469,864 (Direct) | View |
| 2025-12-15 Sale | 2025-12-17 4:10 pm | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 3,452 | $12.92 | $44,600 | 10,252 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:42 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 4,175,139 | $13.98 | $58,377,021 | 6,053,960 (Indirect) | View |
| 2025-11-19 Sale | 2025-11-21 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 15,000 | $11.03 | $165,495 | 484,864 (Direct) | View |
| 2025-05-08 Sale | 2025-05-09 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 498 | $5.06 | $2,520 | 14,062 (Direct) | View |
| 2024-05-07 Sale | 2024-05-09 4:10 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 236 | $7.76 | $1,831 | 11,571 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-04 4:10 pm | N/A 2036-02-01 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:10 pm | N/A 2036-02-01 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:10 pm | N/A 2036-02-01 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 57,000 | $0 | 57,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:10 pm | N/A 2036-02-01 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 650,000 | $0 | 650,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | King Rachel K. Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Hill Colin Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 4:15 pm | N/A 2035-06-25 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2025-01-24 Option Award | 2025-01-28 4:15 pm | N/A 2035-01-23 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 285,000 | $0 | 285,000 (Direct) | View |
| 2025-01-24 Option Award | 2025-01-28 4:15 pm | N/A 2035-01-23 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 582,000 | $0 | 582,000 (Direct) | View |
| 2025-01-24 Option Award | 2025-01-28 4:15 pm | N/A 2035-01-23 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 76,120 | $0 | 76,120 (Direct) | View |
| 2025-01-24 Option Award | 2025-01-28 4:15 pm | N/A 2035-01-24 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-11-12 Option Award | 2024-11-14 4:15 pm | N/A 2034-11-11 | Fulcrum Therapeutics Inc. | FULC | King Rachel K. Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2024-09-23 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 18,729,099 (Indirect) | View |
| 2024-08-21 Other | 2024-08-23 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 8,500,000 | $0 | 20,109,704 (Indirect) | View |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $0 | 2,473,760 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $3.27 | 2,473,760 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Hill Colin Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2024-06-18 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Hill Colin Director | 0 | $0 | 0 (Direct) | View |
| 2024-03-18 Option Award | 2024-03-20 4:15 pm | N/A 2034-03-17 | Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2024-03-20 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer | 0 | $0 | 0 (Direct) | View |